The pharmaceutical industry’s approach to data integrity has been historically manual, leveraging physical documentation and potentially unreliable paper-based ...
The US Food and Drug Administration (FDA) released a draft guidance on April 3 providing recommendations to sponsors and testing sites on data integrity for bioavailability and bioequivalence (BA/BE) ...
Case studies show connected analytics can shift tradeoffs to triumphs. At Fierce Pharma Week in Philadelphia, Veeva’s Anthony Billinger, Senior Director of Compass Strategy, emphasized the challenges ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback